A-443654, an AKT pathway inhibitor, suppresses tumor growth by inducing apoptosis and may further sensitize NSCLC cells to ferroptosis through metabolic reprogramming and inhibition of survival signaling (81–83). Here, AKT1 is linked to neoplasm.